News & Views
Cell Bank In Developmental Stages
Apr 11 2011
Advanced Cell Technology Inc has signed a Memorandum of Understanding with Scotland-based Roslin Cells Ltd. to create a human embryonic stem cell (hESC) bank that the company said will meet the development and storage standards of the U.S. Food and Drug Administration and the European Medicines Agency.
The hESC bank will be available for research and commercial use, the Marlborough-based firm noted Roslin Cells will maintain the stem cell bank and promote access to the hESC lines. The two companies will also make available a commercialisation license, from which Roslin Cells and ACT will split the proceeds, milestone payments and royalty payments. ACT uses its single blastomere technique in obtaining the hESCs. “In stark contrast to embryonic stem cells lines currently available for research, such as those on the NIH registry, our single blastomere technique does not destroy the embryo,” said ACT Chief Scientific Officer Robert Lanza.
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Nov 27 2024 Istanbul, Turkey
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE